
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials

The American Dream Monthly: July 2024

California’s Golden Opportunity: More Foreign Investment from China

Milken Institute Expands in Asia with Appointment of Two Fellows
